David Stamler

David Stamler

Directeur Général chez ALTERITY THERAPEUTICS LIMITED

Fortune : 689 389 $ au 31/08/2026

65 ans
Health Technology
Consumer Services
Commercial Services

Profil

Dr. David A. Stamler, MD, is a Chief Executive Officer, MD & Director at Alterity Therapeutics Ltd. He is on the Board of Directors at Alterity Therapeutics Ltd. Dr. Stamler was previously employed as a Vice President-Clinical Development & Therapeutic by Teva Pharmaceutical Industries Ltd., a Chief Medical Officer by Auspex Pharmaceuticals, Inc., a Chief Medical Officer & Senior Vice President by XenoPort, Inc., a Chief Scientific Officer & Head-Drug Development by Prestwick Pharmaceuticals, Inc., a Senior Global Project Leader-CNS Diseases by Fujisawa Pharmaceutical Co., Ltd., a Vice President- Clinical Research Center by Astellas Research Institute of America LLC, a Vice President-Research & Development by Fujisawa Healthcare, Inc., and a Director-Clinical Research by Abbott Laboratories.
He received his undergraduate degree from The University of Chicago and a doctorate degree from Pritzker School of Medicine.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
31/08/2026 1 904 863 ( 0,87% ) 689 389 $ 31/08/2026

Postes actifs de David Stamler

SociétésPosteDébut
ALTERITY THERAPEUTICS LIMITED Directeur Général 07/01/2021

Anciens postes connus de David Stamler

SociétésPosteFin
TEVA PHARMACEUTICAL INDUSTRIES LIMITED Corporate Officer/Principal 01/01/2017
AUSPEX PHARMACEUTICALS INC Directeur Technique/Scientifique/R&D 05/05/2015
XENOPORT, INC. Directeur Technique/Scientifique/R&D 19/11/2010
Directeur Technique/Scientifique/R&D 01/01/2008
Corporate Officer/Principal 01/01/2005
Voir l'expérience en détail de David Stamler

Formation de David Stamler

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

68

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées11

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Fujisawa Healthcare, Inc.

Commercial Services

Health Technology

Consumer Services

  1. Bourse
  2. Insiders
  3. David Stamler
-40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT